Misplaced Pages

Bromodeoxyuridine

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Bromodeoxyuridine ( 5-bromo-2'-deoxyuridine , BrdU , BUdR , BrdUrd , broxuridine ) is a synthetic nucleoside analogue with a chemical structure similar to thymidine . BrdU is commonly used to study cell proliferation in living tissues and has been studied as a radiosensitizer and diagnostic tool in people with cancer .

#54945

29-552: During the S phase of the cell cycle (when DNA replication occurs), BrdU can be incorporated in place of thymidine in newly synthesized DNA molecules of dividing cells. Cells that have recently performed DNA replication or DNA repair can be detected with antibodies specific for BrdU using techniques such as immunohistochemistry or immunofluorescence . BrdU-labelled cells in humans can be detected up to two years after BrdU infusion. Because BrdU can replace thymidine during DNA replication, it can cause mutations , and its use

58-509: A conserved 3` stem loop motif that selective binds to Stem Loop Binding Protein ( SLBP ). SLBP binding is required for efficient processing, export, and translation of histone mRNAs, allowing it to function as a highly sensitive biochemical "switch". During S-phase, accumulation of SLBP acts together with NPAT to drastically increase the efficiency of histone production. However, once S-phase ends, both SLBP and bound RNA are rapidly degraded. This immediately halts histone production and prevents

87-466: A positive feedback loop similar to the one found in yeast. Throughout M phase and G1 phase, cells assemble inactive pre-replication complexes (pre-RC) on replication origins distributed throughout the genome. During S-phase, the cell converts pre-RCs into active replication forks to initiate DNA replication. This process depends on the kinase activity of Cdc7 and various S-phase CDKs, both of which are upregulated upon S-phase entry. Activation of

116-515: A positive feedback loop that fully commits cells to S-phase gene expression. A remarkably similar regulatory scheme exists in mammalian cells. Mitogenic signals received throughout G1-phase cause gradual accumulation of cyclin D, which complexes with CDK4/6. Active cyclin D-CDK4/6 complex induces release of E2F transcription factor, which in turn initiates expression of S-phase genes. Several E2F target genes promote further release of E2F, creating

145-611: A second DNA binding site, increasing E2F binding stability. Most E2F have a pocket protein binding domain. Pocket proteins such as pRB and related proteins p107 and p130, can bind to E2F when hypophosphorylated. In activators, E2F binding with pRB has been shown to mask the transactivation domain responsible for transcription activation. In repressors E2F4 and E2F5, pocket protein binding (more often p107 and p130 than pRB) mediates recruitment of repression complexes to silence target genes. E2F6, E2F7, and E2F8 do not have pocket protein binding sites and their mechanism for gene silencing

174-442: A toxic buildup of free histones. Free histones produced by the cell during S-phase are rapidly incorporated into new nucleosomes. This process is closely tied to the replication fork, occurring immediately in “front” and “behind” the replication complex. Translocation of MCM helicase along the leading strand disrupts parental nucleosome octamers, resulting in the release of H3-H4 and H2A-H2B subunits. Reassembly of nucleosomes behind

203-652: Is a great deal of redundancy among the family members. Mouse embryos lacking E2F1, E2F2, and one of the E2F3 isoforms, can develop normally when either E2F3a or E2F3b, is expressed. The E2F family is generally split by function into two groups: transcription activators and repressors. Activators such as E2F1, E2F2, E2F3a promote and help carryout the cell cycle, while repressors inhibit the cell cycle. Yet, both sets of E2F have similar domains. E2F1-6 have DP1,2 heterodimerization domain which allows them to bind to DP1 or DP2, proteins distantly related to E2F. Binding with DP1,2 provides

232-532: Is activated by phosphorylation and recruits the Tip60 chromatin remodeling complex to the promoters of histone genes. Tip60 activity removes inhibitory chromatin structures and drives a three to ten-fold increase in transcription rate. In addition to increasing transcription of histone genes, S-phase entry also regulates histone production at the RNA level. Instead of polyadenylated tails , canonical histone transcripts possess

261-421: Is biased towards identifying microorganisms with A- and T-rich genomes. DNA with BrdU transcribes as usual DNA, with guanine included in RNA as a complement to BrdU. S phase S phase ( Synthesis phase ) is the phase of the cell cycle in which DNA is replicated , occurring between G 1 phase and G 2 phase . Since accurate duplication of the genome is critical to successful cell division,

290-440: Is controlled by molecular pathways that facilitate a rapid, unidirectional shift in cell state. In yeast, for instance, cell growth induces accumulation of Cln3 cyclin , which complexes with the cyclin dependent kinase CDK2. The Cln3-CDK2 complex promotes transcription of S-phase genes by inactivating the transcriptional repressor Whi5 . Since upregulation of S-phase genes drive further suppression of Whi5 , this pathway creates

319-571: Is in transcriptional repressive complexes with the pocket proteins. pRb is one of the targets of the oncogenic human papilloma virus protein E7, and human adenovirus protein E1A. By binding to pRB, they stop the regulation of E2F transcription factors and drive the cell cycle to enable virus genome replication. Activators are maximally expressed late in G1 and can be found in association with E2F regulated promoters during

SECTION 10

#1732851088055

348-418: Is not associated with activation of canonical DNA damage pathways, indicating that nucleosome assembly and histone supply may be scrutinized by a novel S-phase checkpoint. E2F E2F is a group of genes that encodes a family of transcription factors (TF) in higher eukaryotes . Three of them are activators : E2F1, 2 and E2F3a. Six others act as repressors : E2F3b, E2F4-8. All of them are involved in

377-456: Is only expressed in terminally differentiated cells in mice. The balance between repressor and activator E2F regulate cell cycle progression. When activator E2F family proteins are knocked out, repressors become active to inhibit E2F target genes. The Rb tumor suppressor protein (pRb) binds to the E2F1 transcription factor preventing it from interacting with the cell's transcription machinery. In

406-926: Is probably controlled by incorporation of histone variants during nucleosome reassembly. The close correlation seen between H3.3/H2A.Z and transcriptionally active regions lends support to this proposed mechanism. Unfortunately, a causal relationship has yet to be proven. During S-phase, the cell continuously scrutinizes its genome for abnormalities. Detection of DNA damage induces activation of three canonical S-phase "checkpoint pathways" that delay or arrest further cell cycle progression: In addition to these canonical checkpoints, recent evidence suggests that abnormalities in histone supply and nucleosome assembly can also alter S-phase progression. Depletion of free histones in Drosophila cells dramatically prolongs S-phase and causes permanent arrest in G2-phase. This unique arrest phenotype

435-520: Is sufficient for accurate re-establishment of chromatin domains. Polycomb Repressive Complex 2 ( PRC2 ) and several other histone-modifying complexes can "copy" modifications present on old histones onto new histones. This process amplifies epigenetic marks and counters the dilutive effect of nucleosome duplication. However, for small domains approaching the size of individual genes, old nucleosomes are spread too thinly for accurate propagation of histone modifications. In these regions, chromatin structure

464-670: Is therefore potentially a health hazard. However, because it is neither radioactive nor myelotoxic at labeling concentrations, it is widely preferred for in vivo studies of cancer cell proliferation. However, at radiosensitizing concentrations, BrdU becomes myelosuppressive, thus limiting its use for radiosensitizing. BrdU differs from thymidine in that BrdU substitutes a bromine atom for thymidine's CH 3 group. The Br substitution can be used in X-ray diffraction experiments in crystals containing either DNA or RNA. The Br atom acts as an anomalous scatterer and its larger size will affect

493-584: Is unclear. Cdk4(6)/cyclin D and cdk2/cyclin E phosphorylate pRB and related pocket proteins allowing them to disassociate from E2F. Activator E2F proteins can then transcribe S phase promoting genes. In REF52 cells, overexpression of activator E2F1 is able to push quiescent cells into S phase. While repressors E2F4 and 5 do not alter cell proliferation, they mediate G1 arrest. E2F activator levels are cyclic, with maximal expression during G1/S. In contrast, E2F repressors stay constant, especially since they are often expressed in quiescent cells. Specifically, E2F5

522-611: The cell cycle regulation and synthesis of DNA in mammalian cells. E2Fs as TFs bind to the TTTCCCGC (or slight variations of this sequence) consensus binding site in the target promoter sequence. Schematic diagram of the amino acid sequences of E2F family members ( N-terminus to the left, C-terminus to the right) highlighting the relative locations of functional domains within each member: Homo sapiens E2F1 mRNA or E2F1 protein sequences from NCBI protein and nucleotide database. X-ray crystallographic analysis has shown that

551-632: The E2F family of transcription factors has a fold similar to the winged-helix DNA-binding motif . E2F family members play a major role during the G1/S transition in mammalian and plant cell cycle (see KEGG cell cycle pathway ). DNA microarray analysis reveals unique sets of target promoters among E2F family members suggesting that each protein has a unique role in the cell cycle. Among E2F transcriptional targets are cyclins , CDKs , checkpoints regulators, DNA repair and replication proteins. Nonetheless, there

580-694: The G1/S transition. The activation of E2F-3a genes follows upon the growth factor stimulation and the subsequent phosphorylation of the E2F inhibitor retinoblastoma protein, pRB . The phosphorylation of pRB is initiated by cyclin D / cdk4 , cdk6 complex and continued by cyclin E/cdk2. Cyclin D/cdk4,6 itself is activated by the MAPK signaling pathway . When bound to E2F-3a, pRb can directly repress E2F-3a target genes by recruiting chromatin remodeling complexes and histone modifying activities (e.g. histone deacetylase, HDAC ) to

609-745: The absence of pRb, E2F1 (along with its binding partner DP1) mediates the trans-activation of E2F1 target genes that facilitate the G1/S transition and S-phase. E2F targets genes that encode proteins involved in DNA replication (for example DNA polymerase , thymidine kinase , dihydrofolate reductase and cdc6 ), and chromosomal replication (replication origin-binding protein HsOrc1 and MCM5 ). When cells are not proliferating, E2F DNA binding sites contribute to transcriptional repression. In vivo footprinting experiments obtained on Cdc2 and B-myb promoters demonstrated E2F DNA binding site occupation during G0 and early G1, when E2F

SECTION 20

#1732851088055

638-625: The crystal's X-ray diffraction enough to detect isomorphous differences as well. Bromodeoxyuridine releases gene silencing caused by DNA methylation. BrdU can also be used to identify microorganisms that respond to specific carbon substrates in aquatic and soil environments. A carbon substrate added to the incubations of environmental samples will cause the growth of microorganisms that can utilize that substrate. These microorganisms will then incorporate BrdU into their DNA as they grow. Community DNA can then be isolated and BrdU-labeled DNA purified using an immunocapture technique. Subsequent sequencing of

667-461: The flexibility of DNA replication, allowing cells to control the rate of DNA synthesis and respond to replication stress. Since new DNA must be packaged into nucleosomes to function properly, synthesis of canonical (non-variant) histone proteins occurs alongside DNA replication. During early S-phase, the cyclin E-Cdk2 complex phosphorylates NPAT , a nuclear coactivator of histone transcription. NPAT

696-559: The formation of nucleosomes that either contain exclusively old H3-H4 or exclusively new H3-H4. “Old” and “new” histones are assigned to each daughter strand semi-randomly, resulting in equal division of regulatory modifications. Immediately after division, each daughter chromatid only possesses half the epigenetic modifications present in the paternal chromatid. The cell must use this partial set of instructions to re-establish functional chromatin domains before entering mitosis. For large genomic regions, inheritance of old H3-H4 nucleosomes

725-422: The labeled DNA can then be used to identify the microbial taxa that participated in the degradation of the added carbon source. However, it is not certain whether all microbes present in an environmental sample can incorporate BrdU into their biomass during de novo DNA synthesis. Therefore, a group of microorganisms may respond to a carbon source but go undetected using this technique. Additionally, this technique

754-417: The pre-RC is a closely regulated and highly sequential process. After Cdc7 and S-phase CDKs phosphorylate their respective substrates, a second set of replicative factors associate with the pre-RC. Stable association encourages MCM helicase to unwind a small stretch of parental DNA into two strands of ssDNA, which in turn recruits replication protein A ( RPA ), an ssDNA binding protein. RPA recruitment primes

783-471: The processes that occur during S-phase are tightly regulated and widely conserved. Entry into S-phase is controlled by the G1 restriction point (R), which commits cells to the remainder of the cell-cycle if there is adequate nutrients and growth signaling. This transition is essentially irreversible; after passing the restriction point, the cell will progress through S-phase even if environmental conditions become unfavorable. Accordingly, entry into S-phase

812-441: The replication fork for loading of replicative DNA polymerases and PCNA sliding clamps. Loading of these factors completes the active replication fork and initiates synthesis of new DNA. Complete replication fork assembly and activation only occurs on a small subset of replication origins. All eukaryotes possess many more replication origins than strictly needed during one cycle of DNA replication. Redundant origins may increase

841-453: The replication fork is mediated by chromatin assembly factors (CAFs) that are loosely associated with replication proteins. Though not fully understood, the reassembly does not appear to utilize the semi-conservative scheme seen in DNA replication. Labeling experiments indicate that nucleosome duplication is predominantly conservative. The paternal H3-H4 core nucleosome remains completely segregated from newly synthesized H3-H4, resulting in

#54945